Screener
Asset Entities ASST Medical Device — Operating Expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| General and administrative expense | 6,428 | 1,452 |
| Marketing and advertising | 79 | 102 |
| Depreciation and amortization | 86 | 54 |
| Total operating expenses | 24,396 | 5,201 |
| Investment losses: | ||
| Net unrealized loss on digital assets, at fair value | (228,031) | — |
| Net unrealized loss on investments in preferred equity, at fair value | (5,962) | — |
| Other investment loss | (2,801) | — |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — operating expenses?
- Asset Entities (ASST) reported medical device — operating expenses of $6.6M in Q2 2026.
- What does medical device — operating expenses mean?
- This is the sum of all costs incurred to run the day-to-day operations of the business segment, excluding interest and taxes. It provides a comprehensive view of the segment's cost structure and operational burden. Investors use this to calculate the segment's operating margin and overall cost-efficiency.
Ask your AI about Asset Entities's medical device — operating expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude